Diamyd Medical Revenue and Competitors
Estimated Revenue & Valuation
- Diamyd Medical's estimated annual revenue is currently $11.3M per year.
- Diamyd Medical's estimated revenue per employee is $201,000
Employee Data
- Diamyd Medical has 56 Employees.
- Diamyd Medical grew their employee count by 19% last year.
Diamyd Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Director Business Development | Reveal Email/Phone |
4 | Site Manager | Reveal Email/Phone |
5 | US Site Relations and Patient Recruitment Lead | Reveal Email/Phone |
6 | Clinical Program Lead | Reveal Email/Phone |
7 | Process Engineer | Reveal Email/Phone |
8 | Production Scientist | Reveal Email/Phone |
9 | Production scientist | Reveal Email/Phone |
10 | GMP-specialist | Reveal Email/Phone |
Diamyd Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.3M | 106 | 25% | N/A | N/A |
#2 | $61.7M | 307 | 5% | N/A | N/A |
#3 | $15.1M | 75 | -12% | N/A | N/A |
#4 | $120.6M | 600 | 22% | N/A | N/A |
#5 | $29.7M | 148 | 21% | N/A | N/A |
#6 | $27.7M | 138 | -67% | N/A | N/A |
#7 | $31.2M | 155 | 14% | N/A | N/A |
#8 | $25.3M | 126 | 29% | N/A | N/A |
#9 | $108.7M | 541 | 26% | N/A | N/A |
#10 | $1200M | 1397 | -6% | $2.4B | N/A |
What Is Diamyd Medical?
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively in-licensed GAD molecule. In-licensed technologies for GABA and Gliadin also have potential to become a key piece of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes and other inflammation-related conditions. Diamyd Medical's share is traded on Nasdaq Stockholm First North, ticker DMYD B.
keywords:N/A
N/A
Total Funding
56
Number of Employees
$11.3M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diamyd Medical News
Diamyd Medical develops precision medicine therapies for type 1 diabetes. The diabetes vaccine Diamyd® is an antigen-specific immunotherapy...
Diamyd Medical AB, of Stockholm, highlighted an update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes...
Diamyd Medical AB (publ) (STO:DMYD B) insiders who sold earlier this year missed the bus as stock gained 11% last week · The Last 12 Months Of...
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.3M | 56 | -58% | N/A |
#2 | $12.8M | 56 | 22% | N/A |
#3 | $7.3M | 56 | 87% | N/A |
#4 | $16.3M | 56 | -11% | N/A |
#5 | $11.1M | 56 | 40% | N/A |